Skip to main content
Caplight Logo









Neurescue

Neurescue

Private
CopenhagenHealthcare & Life Scienceshttps://neurescue.com

Last Round

Series A

Feb 5, 2024

Total Funding Raised

$9.74M

Company Overview

Neurescue operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Series A round in February 2024.

Neurescue is a medical device company that develops cardiovascular devices to improve outcomes for emergency patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Neurescue Comparables

Compare Neurescue with similar companies based on industry and business-model similarity.

No comparables are published for Neurescue. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Neurescue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 5, 2024
GrantAug 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Bjørn Broby Glavind

COO & Associate Co-founder

Founding Team

Habib Frost

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Neurescue Investors

Notable investors and investment history

Neurescue investors
InvestorRounds
Innovation Fund DenmarkGrant
European CommissionGrant
West Hill CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 5, 2024

    $7.2M round led by West Hill Capital

  • Aug 1, 2018

    $1.84M grant received from the European Commission.

Book a demo to see all signals

For institutional investors. Book with your work email.

Neurescue Filings

Explore SEC and related filing metadata, where available.

Neurescue filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Neurescue's valuation, stock price, and market status.

Is Neurescue a public or private company?

Neurescue is a private company.

What is the current stock price of Neurescue?

Neurescue is a private company, so its shares have no public market price. Caplight tracks Neurescue's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Neurescue worth (valuation)?

Valuation information for Neurescue is not publicly available.

Can I buy Neurescue stock?

Neurescue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Neurescue's last funding round?

Neurescue's most recent funding round was Series A on February 5, 2024.

Who are the main investors in Neurescue?

Key investors in Neurescue include West Hill Capital.

Will Neurescue IPO soon?

No public IPO plans have been announced for Neurescue.

How can I track Neurescue secondary market activity?

Caplight tracks bids, offers, and trades in Neurescue's shares on secondary markets.

Firmographic Details

HeadquartersCopenhagen
Employee Range17
Year Founded2014
Last FundingFeb 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?